These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3669055)

  • 21. Serological and biochemical characteristics of virulence plasmid of Yersinia enterocolitica isolates from chicken in the Islamic Republic of Iran.
    Motallebi M; Zamani MR; Saffar B
    East Mediterr Health J; 2000; 6(2-3):409-15. PubMed ID: 11556031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the pathogenicity of Yersinia enterocolitica. III. Comparative studies between Y. enterocolitica and Y. pseudotuberculosis.
    Une T
    Microbiol Immunol; 1977; 21(9):505-16. PubMed ID: 593171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression in vivo of additional plasmid-mediated proteins during intestinal infection with Yersinia enterocolitica serotype O8.
    Naumann M; Hanski C; Riecken EO
    J Med Microbiol; 1991 Nov; 35(5):257-63. PubMed ID: 1941997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Plasmid-mediated pathogenicity factors of Yersinia enterocolitica from the epidemiological viewpoint].
    Hammerschmidt W; Hellmann E
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):323-42. PubMed ID: 6485634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of a novel porin involved in systemic Yersinia enterocolitica infection.
    Mildiner-Earley S; Miller VL
    Infect Immun; 2006 Jul; 74(7):4361-5. PubMed ID: 16790812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection against Yersinia infection induced by non-virulence-plasmid-encoded antigens.
    Simonet M; Berche P; Mazigh D; Veron M
    J Med Microbiol; 1985 Oct; 20(2):225-31. PubMed ID: 3900406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Murine neonates infected with Yersinia enterocolitica develop rapid and robust proinflammatory responses in intestinal lymphoid tissues.
    Siefker DT; Echeverry A; Brambilla R; Fukata M; Schesser K; Adkins B
    Infect Immun; 2014 Feb; 82(2):762-72. PubMed ID: 24478090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on pathogenicity of Yersinia enterocolitica in mice with diabetes mellitus.
    Dima VF; Ionescu MD; Popa C; Balotescu C; Laky D; Dima SV
    Roum Arch Microbiol Immunol; 1999; 58(2):157-76. PubMed ID: 11845454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the usefulness of selected virulence markers for identification of virulent Yersinia enterocolitica strains. II. Genotypic markers associated with the pYV plasmid].
    Gierczyński R
    Med Dosw Mikrobiol; 2000; 52(1):35-49. PubMed ID: 11107778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unique virulence properties of Yersinia enterocolitica O:3--an emerging zoonotic pathogen using pigs as preferred reservoir host.
    Valentin-Weigand P; Heesemann J; Dersch P
    Int J Med Microbiol; 2014 Oct; 304(7):824-34. PubMed ID: 25172222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arthritogenicity of genetically manipulated Yersinia enterocolitica serotype O8 for Lewis rats.
    Gaede KI; Heesemann J
    Infect Immun; 1995 Feb; 63(2):714-9. PubMed ID: 7822048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the course of infection of virulent Yersinia enterocolitica serotype O:8 with an isogenic sodA mutant in the peroral rabbit model.
    Najdenski HM; Golkocheva EN; Vesselinova AM; Rüssmann H
    Int J Med Microbiol; 2004 Oct; 294(6):383-93. PubMed ID: 15595388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenicity of various Yersinia enterocolitica serotypes towards mice of Swiss and Balb/c strains.
    Zaremba M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):611-7. PubMed ID: 749814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of Yersinia enterocolitica to rabbit intestinal brush border membranes, mucus, and mucin.
    Mantle M; Basaraba L; Peacock SC; Gall DG
    Infect Immun; 1989 Nov; 57(11):3292-9. PubMed ID: 2807525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of a 70 kilobase virulence plasmid on the ability of Yersinia enterocolitica to survive phagocytosis in vitro.
    Tabrizi SN; Robins-Browne RM
    Microb Pathog; 1992 Sep; 13(3):171-9. PubMed ID: 1291840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the usefulness of selected virulence markers for the identification of virulent Yersinia enterocolitica strains. I. Phenotypic markders associated with Plasmid pYV].
    Gierczyński R
    Med Dosw Mikrobiol; 2000; 52(1):25-34. PubMed ID: 11107777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmid-mediated resistance to phagocytosis in Yersinia enterocolitica.
    Lian CJ; Hwang WS; Pai CH
    Infect Immun; 1987 May; 55(5):1176-83. PubMed ID: 3570459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental infection of mice with Yersinia strains bearing or not bearing the virulence-associated plasmid.
    Bauab TM; Falcão DP
    Contrib Microbiol Immunol; 1991; 12():144-55. PubMed ID: 1935082
    [No Abstract]   [Full Text] [Related]  

  • 39. Virulence of Yersinia spp. strains isolated from non-human sources.
    Apfel MI; Noleto AL
    Braz J Med Biol Res; 1991; 24(8):777-86. PubMed ID: 1797265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell adherence--a determinant of virulence in Yersinia enterocolitica.
    Lal M; Kaur H; Gupta LK; Roma I
    Indian J Pathol Microbiol; 2006 Jan; 49(1):49-50. PubMed ID: 16625978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.